Evidence map›Paper›PMID 35385209›Full record

Trial reportMolecular nutrition & food research2022

No Effect of Isolated Anthocyanins from Bilberry Fruit and Black Rice on LDL Cholesterol or other Biomarkers of Cardiovascular Disease in Adults with Elevated Cholesterol: A Randomized, Placebo-Controlled, Cross-Over Trial.

Hassan Aboufarrag, Wendy J Hollands, Jasmine Percival, Mark Philo, George M Savva, Paul A Kroon

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Molecular nutrition & food research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 4 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Hassan AboufarragQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Wendy J HollandsQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.ORCID 0000-0001-5925-9170
Jasmine PercivalQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Mark PhiloQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
George M SavvaQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.
Paul A KroonQuadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK.ORCID 0000-0002-9805-6947
Norwich Research Park · GB

Funding

Biotechnology and Biological Sciences Research Council BB/M011216/1Biotechnology and Biological Sciences Research Council BB/R012512/1Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10343Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10346Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10347
6 · The paper itself

Abstract

scopeSome dietary interventions with berry fruits, berry fruit extracts, and purified anthocyanins have been reported to beneficially alter lipoprotein profiles in hyperlipidemic participants. The major anthocyanins in human diets are glycosides of cyanidin and delphinidin, and structure can influence both absorption and bioactivity. The aim of this study is to determine the effects of two major types of anthocyanins on low-density lipoprotein cholesterol and other cardiometabolic markers for cardiovascular disease (CVD) risk in hyperlipidemic individuals. METHODS AND

resultsFifty-two hyperlipidemic participants complete this randomized, placebo-controlled, double-blind, three arm crossover trial. Participants ingest capsules containing 320 mg of anthocyanins (bilberry trihydroxy-type or black rice dihydroxy-type) or placebo once daily for 28 days. Biomarkers of CVD risk are measured before and after the intervention period. Compared to the placebo, neither anthocyanin treatment significantly (p < 0.05) changes circulating levels of lipoproteins (total-/high-density lipoprotein (HDL)-/low-density lipoprotein (LDL)-cholesterol, triglycerides, Apolipoprotein B (ApoB)), biomarkers of glycemic control (fasting glucose, fructosamine), biomarkers of HDL function (ApoA1, HDL3, paraoxonase-1 (PON1) arylesterase, and lactonase activities), or plasma bile acids.

conclusionsThese data do not support the notion that regular consumption of anthocyanins beneficially affects glycemic control or lipoprotein profiles or functions. It is possible the no effect observation is due to the relatively short duration of treatments.

Indexed as

Cardiovascular DiseasesHypercholesterolemiaOryzaVaccinium myrtillusAdultAnthocyaninsAryldialkylphosphataseBiomarkersCholesterolCholesterol, LDLCross-Over StudiesFruitHumansLipoproteins, HDLAnthocyaninsAryldialkylphosphataseBiomarkersCholesterolCholesterol, LDLLipoproteins, HDLPON1 protein, humanflavonoidsglucose controllow density lipoproteinparaoxonase-1Vaccinium myrtillus

Identifiers

PMID35385209
PMCPMC9788215
OpenAlexW4224989440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.